Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study

Streptococcus infantis, Streptococcus mitis, and Streptococcus oralis Strains With Highly Similar cps5 Loci and Antigenic Relatedness to Serotype 5 Pneumococci

(2019) Fabiana Pimenta et al.   Frontiers in Microbiology

Relative effectiveness of revaccination with 23-valent pneumococcal polysaccharide vaccine in preventing invasive pneumococcal disease in adult Aboriginal and Torres Strait Islander people, Australia

(2019) Mari Takashima et al.   VACCINE

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis

(2019) Nirma Khatri Vadlamudi et al.   VACCINE

Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study

(2019) Jong Hun Kim et al.   VACCINE

Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia

(2019) Raul E. Isturiz et al.   VACCINE

Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis

(2019) John M. McLaughlin et al.   VACCINE

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control

(2018) Dominic Thorrington et al.   BMC Medicine

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

(2018) Shamez N Ladhani et al.   LANCET INFECTIOUS DISEASES

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands

(2018) Dominic Thorrington et al.   PLoS One

Vaccination in the elderly: The challenge of immune changes with aging

(2018) Annalisa Ciabattini et al.   SEMINARS IN IMMUNOLOGY

Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study

(2017) Motoi Suzuki et al.   LANCET INFECTIOUS DISEASES

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

(2015) Chamira Rodrigo et al.   EUROPEAN RESPIRATORY JOURNAL

Dosing regimen of the 23-valent pneumococcal vaccination: A systematic review

(2015) Chelsea A. Caya et al.   VACCINE

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia

(2013) R. L. Sherwin et al.   JOURNAL OF INFECTIOUS DISEASES

Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

(2013) Maria A. Said et al.   PLoS One

Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status

(2013) Chamira Rodrigo et al.   THORAX

DAGitty

(2011) Johannes Textor et al.   EPIDEMIOLOGY

Factors associated with pneumococcal and influenza vaccination in hospitalized people aged ⩾65 years

(2010) X. SINTES et al.   EPIDEMIOLOGY AND INFECTION

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Large Community Outbreak ofStreptococcus pneumoniaeSerotype 5 Invasive Infection in an Impoverished, Urban Population

(2008) Marc G. Romney et al.   CLINICAL INFECTIOUS DISEASES